DAVID HICKS: Open Payments
NPI 1093904815 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,387 in 242 payments from 35 companies in 2025. Trend: 2023 $4,817 · 2024 $5,480 · 2025 $5,387
Food & beverage: $5,387
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $679 |
| ABBVIE INC. | 21 | $537 |
| PFIZER INC. | 20 | $471 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $367 |
| Otsuka America Pharmaceutical, Inc. | 15 | $347 |
| GlaxoSmithKline, LLC. | 13 | $272 |
| Novo Nordisk Inc | 13 | $267 |
| Corcept Therapeutics | 10 | $263 |
| Kowa Pharmaceuticals America, Inc. | 33 | $218 |
| UCB, Inc. | 8 | $213 |
Products named: Auvelity, REXULTI, VRAYLAR, NURTEC ODT, CAPLYTA, Korlym, TRELEGY ELLIPTA, ZORYVE.
Industry payments across FL — which companies pay providers there.
